Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan

Publication ,  Conference
Moore, H; Shofer, S; Guisinger, A; Broadwater, G; Force, J; Sammons, S; Anders, C; Westbrook, K
Published in: Cancer Research
2021

Published In

Cancer Research

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moore, H., Shofer, S., Guisinger, A., Broadwater, G., Force, J., Sammons, S., … Westbrook, K. (2021). Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan. In Cancer Research (Vol. 81).
Moore, Heather, Scott Shofer, Amy Guisinger, Gloria Broadwater, Jeremy Force, Sarah Sammons, Carey Anders, and Kelly Westbrook. “Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan.” In Cancer Research, Vol. 81, 2021.

Published In

Cancer Research

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis